Mifepristone/misoprostol- Celopharma/Linepharma

Drug Profile

Mifepristone/misoprostol- Celopharma/Linepharma

Alternative Names: Mifegymiso

Latest Information Update: 28 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Linepharma International Limited
  • Developer Celopharma; Linepharma International Limited
  • Class Abortifacients; Antiprogestogens; Dimethylamines; Estrenes; Oral contraceptives; Oxytocics; Prostaglandins; Small molecules
  • Mechanism of Action Glucocorticoid receptor antagonists; Progesterone receptor antagonists; Prostaglandin E1 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Induced abortion

Most Recent Events

  • 24 Nov 2017 Chemical structure information added
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top